BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Cisplatin
,
rs2230926
,
GATA1
,
T cell receptor signaling pathway
,
HIV infection
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
nk 2 receptors
Summary
General Info
Curated Studies
Most Correlated Studies
T cell chronic lymphocytic leukemia Kit 225 cell responses to interleukin-2
Cutaneous T-Cell lymphoma HuT78 cell line treated with AR-A014418 and/or Enzastaurin
L1000 CMAP - T-cell ALL JURKAT cells treated with small molecule perturbagens
Expression data from human Jurkat T cells exposed to 31 compounds
Activation of Sez-4 T-cell lymphoma cell line with IL-2, IL-15 or IL-21
Explore Curated Studies Results
Literature
Most Relevant Literature
Homology modeling, virtual screening, molecular docking, and ADME approaches to identify a potent ag…
Lys5,MeLeu9,Nle10]-NKA(4-10) induces neurokinin 2 receptor mediated urination and defecation and neu…
IFN-α/β-mediated NK2R expression is related to the malignancy of colon cancer cells.
Congenital ablation of Tacr2 reveals overlapping and redundant roles of NK2R signaling in the contro…
Neurokinin 2 receptor-mediated bladder and colorectal responses in aged spinal cord injured rats.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Be…
Personalized NK Cell Therapy in CBT
Cord Blood Derived Anti-CD19 CAR-Engineered NK Cells for B Lymphoid Malignancies
Adoptive Transfer of Haploidentical NK Cells and N-803
Immunotherapy of Advanced Cancer Using a Combination Nimotuzumab and NK Cells
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ